Search by Drug Name or NDC
NDC 42806-0601-10 Venlafaxine Hydrochloride 37.5 mg/1 Details
Venlafaxine Hydrochloride 37.5 mg/1
Venlafaxine Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Epic Pharma, LLC. The primary component is VENLAFAXINE HYDROCHLORIDE.
Product Information
| NDC | 42806-0601 |
|---|---|
| Product ID | 42806-601_0c60dbaf-630c-bec4-e063-6294a90a7ea2 |
| Associated GPIs | |
| GCN Sequence Number | 046403 |
| GCN Sequence Number Description | venlafaxine HCl CAP ER 24H 37.5 MG ORAL |
| HIC3 | H7C |
| HIC3 Description | SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS) |
| GCN | 16816 |
| HICL Sequence Number | 008847 |
| HICL Sequence Number Description | VENLAFAXINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Venlafaxine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Venlafaxine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 37.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | VENLAFAXINE HYDROCHLORIDE |
| Labeler Name | Epic Pharma, LLC |
| Pharmaceutical Class | Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214654 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42806-0601-10 (42806060110)
| NDC Package Code | 42806-601-10 |
|---|---|
| Billing NDC | 42806060110 |
| Package | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42806-601-10) |
| Marketing Start Date | 2022-09-07 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.1004 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | VENLAFAXINE HCL ER 37.5 MG CAP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis